Regional Activation of Leukocytes in Coronary artery disease And Diabetes mellitus (REAL-CAD)

Regional Activation of Leukocytes in Coronary artery disease And Diabetes mellitus (REAL-CAD) - REAL-CAD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30068

Enrollment

120

Registered

2007-01-03

Start date

2007-01-15

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis coronary artery disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects scheduled to undergo a coronary catheterization Aged >18 and

Exclusion criteria

Exclusion criteria: Emotionally and intellectually not capable to decide about participation in the study and the consequences of participation. Subjects who are not able to understand the patient information Unstable angina pectoris CABG or PTCA during the last 6 months Alcohol use > 2 units/day Aberrations in kidney, liver and thyroid function Use of any experimental medication within 6 months of the catheterization The use of immunosuppressive drugs

Design outcomes

Primary

Measure	Time frame
In this study the inflammation (leukocyte activation markers and complement components) in different vascular beds end the relation with triglycerides and glucose will be investigated in different patient groups. In addition MBL genotypes and serum levels of these patients will be determined to get more insight in the differences between the groups.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results